[해외주식] PIRS Pieris 제약 거대한 업사이드 잠재력 / PIRS Pieris Pharmaceuticals Huge …
주식개미
0
1625
2021.08.18 09:10
Pieris Pharmaceuticals, Inc
CryptoFundManager
Big pharma working with Pieris Pharmaceuticals, Inc. (PIRS):
AZN AstraZeneca 70Mil upfront payment and 5.4Bil potential milestone payments
Boston Pharmaceuticals 10Mil upfront payment and 353Mil potential milestone payments
Genentech member of RHHBY Roche Group 20Mil upfront payment and 1.4Bil potential milestone payments
SGEN Seagen 35Mil upfront payment and 1.2Bil potential milestone payments
Servier 40Mil upfront payment and 447Mil potential milestone payments
inhaled program PRS-220 for the treatment of IPF . selected to receive a Bavarian government grant of approximately $17 million to evaluate the program for post-COVID pulmonary fibrosis
On 8/16/2021 Morgan Stanley reported 1,675,969 shares of PIRS for $6.42Mil, an increase of +104.6% for an ownership of 2.512% in the company
On 4/26/2021 HC Wainwright brokerage Reiterated Rating to Buy and a price target of $9.00
On 6/30/2021 Jefferies Financial Group brokerage Boosted Price Target to Buy from $6.00 to $8.00
Usually i have price targets lower than most analysts, but on PIRS, my price target is 10usd.
I`m looking forward to read your opinion about it.
AZN AstraZeneca 70Mil upfront payment and 5.4Bil potential milestone payments
Boston Pharmaceuticals 10Mil upfront payment and 353Mil potential milestone payments
Genentech member of RHHBY Roche Group 20Mil upfront payment and 1.4Bil potential milestone payments
SGEN Seagen 35Mil upfront payment and 1.2Bil potential milestone payments
Servier 40Mil upfront payment and 447Mil potential milestone payments
inhaled program PRS-220 for the treatment of IPF . selected to receive a Bavarian government grant of approximately $17 million to evaluate the program for post-COVID pulmonary fibrosis
On 8/16/2021 Morgan Stanley reported 1,675,969 shares of PIRS for $6.42Mil, an increase of +104.6% for an ownership of 2.512% in the company
On 4/26/2021 HC Wainwright brokerage Reiterated Rating to Buy and a price target of $9.00
On 6/30/2021 Jefferies Financial Group brokerage Boosted Price Target to Buy from $6.00 to $8.00
Usually i have price targets lower than most analysts, but on PIRS, my price target is 10usd.
I`m looking forward to read your opinion about it.
번역:
피어리스 제약
CryptoFundManager
피에리스 제약(PIRS)과 협력하는 대형 제약사:
AZN Astra Zeneca 7천만 선불 및 5.4마일스톤 지급 청구서
Boston Pharmacutics 선불금 1,000만 건 및 잠재적인 마일스톤 지불액 353백만 건수
RHHBY Roche 그룹 20M 선불 및 1.4의 Genentech 회원마일스톤 지급 청구서
SGEN Seagen 35Mill 선불 및 1.2억의 잠재적 마일스톤 지급
서비어 40Mil 선불 및 447Mil 잠재적 마일스톤 지급
IPF 치료를 위한 흡입 프로그램 PRS-220. COVID 후 폐섬유화 프로그램을 평가하기 위해 약 1,700만 달러의 바이에른 정부 보조금을 받기로 선택됨
Morgan Stanley는 2021년 8월 16일 PIRS의 167만5,969주를 642만 달러에 보고했는데, 이는 PIRS의 2.512% 소유에 대해 +104.6% 증가한 수치입니다.
2021년 4월 26일 HC Wainwright 중개업소는 반복된 구매 등급과 9달러의 가격 목표
2021년 6월 30일 Jefferies Financial Group 중개업체, 6.00달러에서 8.00달러로 가격 목표 상향 조정
보통 저는 대부분의 분석가들보다 가격 목표가 낮지만, PIRS에서는 10usd입니다.
저는 그것에 대한 당신의 의견을 읽고 싶습니다.
원문링크: https://www.tradingview.com/chart/PIRS/dAMMC3GR-PIRS-Pieris-Pharmaceuticals-Huge-Upside-Potential/
[본문뒤 추가문구] 서학개미 투자포럼 - 해외투자 트렌드의 중심
